Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 23, 2020 09:15 ET | Source: BioSig Technologies, Inc.

ViralClear Publishes Comparative In Vitro Data on Merimepodib and Remdesivir Activity Against the COVID-19 Novel Coronavirus in F1000 Research

Westport, CT, April 23, 2020 (GLOBE NEWSWIRE) -- Merimepodib is shown to decrease viral production of COVID-19 coronavirus more than remdesivir at clinically meaningful drug concentrations in...
April 23, 2020 08:45 ET | Source: Center for Introspection & Enlightenment

Everything is One - A New Documentary Film that Decodes the Mystery of Life, Released by Center for Introspection & Enlightenment

SURREY, British Columbia, April 23, 2020 (GLOBE NEWSWIRE) -- Center for Introspection & Enlightenment, Canada has released a new documentary film called Everything is One as a part of its...
April 21, 2020 14:44 ET | Source: Connecticut Science Center

Connecticut Science Center Delivers Online Experiences to Inspire and Educate Amid Coronavirus Crisis

Hartford, Connecticut, April 21, 2020 (GLOBE NEWSWIRE) -- Responding to the urgent need for distance learning and mind-stimulating resources from trusted content providers, the Connecticut Science...
April 21, 2020 14:36 ET | Source: BioSig Technologies, Inc.

Tony Zook Joins the Board of ViralClear Pharmaceuticals, a majority-owned subsidiary of BioSig Technologies, Inc.

Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) -- Former senior executive at AstraZeneca and pharmaceutical industry expert to join as Independent Director The Company is developing Vicromax(tm) – a...
April 21, 2020 10:15 ET | Source: BioSig Technologies, Inc.

BioSig Subsidiary ViralClear Submits Application for Vicromax™ Through FDA’s Coronavirus Treatment Acceleration Program (CTAP) to Seek Acceleration of its Planned Clinical Trials

Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear...
April 20, 2020 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Announces Publication of a Meta-Analysis Demonstrating the Clinical Utility of the GeneSight® Psychotropic Test in People with Major Depressive Disorder

SALT LAKE CITY, April 20, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced...
April 17, 2020 14:07 ET | Source: BioSig Technologies, Inc.

BioSig Issues April 2020 Shareholder Update Letter

Westport, CT, April 17, 2020 (GLOBE NEWSWIRE) -- Information on the progress of our subsidiary ViralClear Pharmaceuticals and Vicromax(tm) – a broad-spectrum orally administered anti-viral candidate...
April 16, 2020 09:45 ET | Source: BioSig Technologies, Inc.

Mayo Clinic preparing to Commence Phase II FDA clinical trial for the treatment of COVID-19 with Vicromax™

Westport, CT, April 16, 2020 (GLOBE NEWSWIRE) -- Broad Spectrum Antiviral Produced by ViralClear Pharmaceuticals, Inc., a subsidiary of BioSig Technologies, Inc.IND filing with FDA expected in...
April 16, 2020 09:00 ET | Source: CereSpir Inc.

CERESPIR INCORPORATED Identifies Possible Link Between COVID-19 Induced Brain Inflammation and Acute Respiratory Stress Syndrome Via Breakdown of the Blood-Brain Barrier

NEW YORK, April 16, 2020 (GLOBE NEWSWIRE) -- CERESPIR INCORPORATED, a pharmaceutical company engaged in the discovery and development of disease modifying therapeutics for the treatment of...
April 13, 2020 15:15 ET | Source: Arizona Science Center

Arizona Science Center Expands Footprint with New Remote Learning Tools

Phoenix, AZ, April 13, 2020 (GLOBE NEWSWIRE) -- During COVID-19 shutdowns, Arizona Science Center continues to build on its mission to inspire, educate and engage curious minds through science. ...